Thromboprophylaxis in medical and surgical patients undergoing physical medicine and rehabilitation: Consensus recommendations

American Journal of Physical Medicine and Rehabilitation

Volumn 85, Issue 2, 2006, Pages 159-166

  Ginzburg, Enrique ^a   Banovac, Kresimir ^b   Epstein, Bryce ^d   Nedd, Kester ^c   Rolnick, Murray ^e   Tannenbaum, Scott ^f  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Spinal Cord Rehabilitation   (United States)

^c JACKSON MEMORIAL HOSPITAL   (United States)

^d Parkway Regional Medical Center ^*  (United States)

^e HEALTHSOUTH Miami Rehabilitation Center   (United States)

^f HEALTHSOUTH Sunrise Rehabilitation Center   (United States)

Author keywords

Heparin; Low Molecular Weight Heparin; Prophylaxis; Thromboembolism

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DALTEPARIN; ENOXAPARIN; EPTIFIBATIDE; FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; STREPTOKINASE; TICLOPIDINE; TINZAPARIN; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN; XIMELAGATRAN;

BLEEDING; BLOOD CLOTTING; BRAIN HEMORRHAGE; CLINICAL RESEARCH; CLINICAL TRIAL; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; DEVICE; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG LABELING; DRUG MEGADOSE; EPIDURAL HEMATOMA; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEMATOMA; HEPARIN INDUCED THROMBOCYTOPENIA; HIGH RISK PATIENT; HUMAN; INJURY; LEG EDEMA; LOW DRUG DOSE; LUNG EMBOLISM; ORTHOPEDIC SURGERY; PHYSICAL MEDICINE; REHABILITATION; REHABILITATION CENTER; REVIEW; SOFT TISSUE DISEASE; SPINAL HEMATOMA; STROKE; SURGICAL PATIENT; THROMBOSIS PREVENTION; UNITED STATES; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT; BANDAGES; CEREBROVASCULAR ACCIDENT; CRITICAL ILLNESS; HUMANS; INTERMITTENT PNEUMATIC COMPRESSION DEVICES; PLATELET AGGREGATION INHIBITORS; PULMONARY EMBOLISM; VENOUS THROMBOSIS; WOUNDS AND INJURIES;

EID: 31544465755     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.phm.0000197581.49272.35     Document Type: Review

References (28)

1. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:338S-400S
2. Lechler E, Schramm W, Flosbach CW: The venous thrombotic risk in non-surgical patients: Epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin). The PRIME Study Group. Haemostasis 1996;26(suppl 2):49-56
3. Geerts WH, Heit JA, Clagett GP, et al: Prevention of venous thromboembolism. Chest 2001;119:132S-75S
4. Lieberman DV, Lieberman D: Proximal deep vein thrombosis after hip fracture surgery in elderly patients despite thromboprophylaxis. Am J Phys Med Rehabil 2002;81:745-50
5. Pietsch M, Kuhle J, Hamer H, et al: Mechanical versus drug prevention of thrombosis after total hip endoprosthesis implantation: A randomized controlled clinical study [in German]. Biomed Tech (Berl) 2003;48:207-12
6. Santori FS, Vitullo A, Stopponi M, et al: Prophylaxis against deep-vein thrombosis in total hip replacement: Comparison of heparin and foot-impulse pump. J Bone Joint Surg Br 1994;76:579-83
7. Warwick D, Harrison J, Whitehouse S, et al: A randomized comparison of a foot pump and low-molecular-weight heparin in the prevention of deep-vein thrombosis after total knee replacement. J Bone Joint Surg Br 2002;84:344-50
8. Fong YK, Ruban P, Yeo SJ, et al: Use of low molecular weight heparin for prevention of deep vein thrombosis in total knee arthroplasty: A study of its efficacy in an Asian population. Ann Acad Med Singapore 2000;29:439-41
9. Francis CW, Berkowitz SD, Comp PC, et al: Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med 2003;349:1703-12
10. Krotenberg R, Adler U, Pomeranz B, et al: Dalteparin vs. enoxaparin for deep vein thrombosis after total hip or knee arthroplasty: A retrospective analysis. Am J Phys Med Rehabil 2001;80:889-95
11. Deitzelzweig SB, Vanscoy GJ, Niccolai CS, et al: Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients. Ann Pharmacother 2003;37:402-11
12. Westrich GH, Haas SB, Mosca P, et al: Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty. J Bone Joint Surg Br 2000;82:795-800
13. Spinal Cord Injury Thromboprophylaxis Investigators: Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: A randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin. J Trauma 2003;54:1116-26
14. Spinal Cord Injury Thromboprophylaxis Investigators: Prevention of venous thromboembolism in the rehabilitation phase after spinal cord injury: Prophylaxis with low-dose heparin or enoxaparin. J Trauma 2003;54:1111-5
15. Geerts WH, Jay RM, Code KI, et al: A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996;335:701-7
16. Ginzburg E, Cohn SM, Lopez J, et al: Comparison of intermittent pneumatic compression devices and low molecular weight heparin in trauma. Br J Surg 2003;90:1338-44
17. Kleber FX, Witt C, Vogel G, et al: Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease: THE-PRINCE Study Group. Am Heart J 2003;145:614-21
18. McGarry LJ, Thompson D: Retrospective database analysis of the prevention of venous thromboembolism with low-molecular-weight heparin in acutely ill medical inpatients in community practice. Clin Ther 2004;26:419-30
19. Buller HR, Davidson BL, Decousus H, et al: Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: A randomized trial. Ann Intern Med 2004;140:867-73
20. Hyers TM, Agnelli G, Hull RD, et al: Antithrombotic therapy for venous thromboembolic disease. Chest 2001;119:176S-93S
21. Hillbom M, Erila T, Sotaniemi K, et al: Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study. Acta Neurol Scand 2002;106:84-92
22. Ginsberg JS, Bates SM, Oczkowski W, et al: Low-dose warfarin in rehabilitating stroke survivors. Thromb Res 2002;107:287-90
23. Kay R, Wong KS, Yu YL, et al: Low-molecular weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995;333:1588-93
24. Pambianco G, Orchard T, Landau P: Deep vein thrombosis: Prevention in stroke patients during rehabilitation. Arch Phys Med Rehabil 1995;76:324-30
25. Bergqvist D, Benoni G, Bjorgell O, et al: Low molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996;335:696-700
26. Prescribing information. Lovenox (enoxaparin sodium injection). Bridgewater, NJ, Aventis Pharmaceuticals, 2004
27. Prescribing information. Fragmin (dalteparin sodium injection). Kalamazoo, MI, Pharmacia and Upjohn, 2004
28. Prescribing information. Arixtra (fondaparinux sodium injection). West Orange, NJ, Organon Sanofi-Syntholabo, 2004